Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT01294436 · COMPLETED

Trial details

NCT number: NCT01294436
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type2 Diabetes High Blood Sugar

Start date: 2011-02-01
Primary completion: 2012-09-01
Enrollment: 728

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.